Hua Medicine (02552) said its loss and total comprehensive expense attributable to owners of the company was RMB235.5 million for the six months ended 30 June 2019, compared to the loss of RMB1.51 billion of the same period last year. The loss per share was RMB0.25. No dividend will be distributed.
The other income was RMB3.38 million, a year-on-year decrease of 50.51%.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
